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Edited by Sandro SonninoAbstract Cryo-electron microscopy has the power to visualise
lipid membranes at the closest to in vivo conditions. The struc-
ture of the lipid bilayer can be well resolved and the interactions
between lipid–protein and protein–protein molecules followed at
the molecular level. We undertook an extended Cryo-electron
microscopy study to follow the factor VIII binding to phosphati-
dylserine containing lipid nanotubes at diﬀerent lipid composi-
tion. Obtaining well ordered tubes is required to deﬁne the
factor VIII membrane-bound structure. The observed alterations
in the arrangement of the protein molecules are indicative for the
ﬂexibility of the membrane-bound factor VIII. Understanding
the signiﬁcance of these conformational changes is essential to
comprehend the function of factor VIII in coagulation and as a
drug for Hemophilia A.
 2008 Federation of European Biochemical Societies.
Published by Elsevier B.V. All rights reserved.
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Coagulation factor VIII (FVIII) is a key protein in haemo-
stasis, essential for blood clotting. Deﬁciency and malfunction
of FVIII result in mild to severe Haemophilia A, a life-threat-
ening blood condition aﬀecting one in 5000 males [1,2].
Upon initiation of the coagulation process, FVIII is cleaved
out from its carrier, the vWF and binds speciﬁcally (Kd =
109) to the phosphatidylserine (PS) rich platelet membrane
[3]. The active form, FVIIIa, acts as a co-factor to factor
IXa (FIXa) forming the membrane-bound Tenase complex,
responsible for the production of FXa and consequently
thrombin. Binding of FVIIIa to the platelet surface and FIXa
enhances the enzyme reaction and thrombin generation by
more than a 100000 times [4]. Thus, the membrane-binding
of FVIIIa is a vital requirement for normal coagulation.
FVIII is a six-domain (A1–A2–B–A3–C1–C2) protein of
2332 amino acids and 280 kDa molecular weight (Mw) [5].
A crystal structure of B-domain less human rFVIII has been
recently solved [6]. Soluble FVIII is a mixture of heterodimers,
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doi:10.1016/j.febslet.2008.04.018domains and variable lengths of the B domain (Mw = 90–
200 kDa), and a light chain (LC) of the A3–C1–C2 domains
(Mw = 80 kDa). The LC and HC are non-covalently linked
via divalent metal ion(s) [7]. Further cleavage at Arg372,
Arg740 and Arg1689, dissociates the A2 and A1 and the HC
to the LC, generating the FVIIIa. Thus, FVIIIa is a heterotri-
mer consisting of the A1, the A2 domains (from the HC) and
the LC (responsible for the membrane binding). All three poly-
peptides are held by non-covalent bounds [8]. Despite intensive
biochemical, biophysical and structural studies, the mem-
brane-bound structure of the FVIII and its functional implica-
tions are yet to be fully understood.
Purifying FVIII from plasma is an expensive and delicate
process, due to its instability and very low concentrations:
3 · 1010 M. To this end, several approved human recombi-
nant FVIII (rFVIII) commercial forms are available, meeting
the criteria for use as a drug against Hemophilia A. Most of
the existing rFVIII forms have been subjected to intensive bio-
chemical, biophysical and structural studies [9,10]. However,
more structural/functional information is required at the clos-
est to in vivo conditions, for which Cryo-electron microscopy
(Cryo-EM) of membrane-bound rFVIII would be a method of
excellence.
Lipid molecules have a tendency to self-organise into lipid
nanotubes (LNT) in the presence of galactosylceramide (GC).
Such systems have been highlighted as suitable for helical crys-
tallization of membrane-associated proteins, easily imaged by
Cryo-EM and allowing further structure determination [11–
14]. Any protein which binds to a speciﬁc ligand incorporated
into the GC-LNT can be subjected to structure determination
by Cryo-EM, as previously demonstrated for model proteins
as streptavidin [15]. If the ligand is aPS, we can speciﬁcally bind
rFVIII and deﬁne its membrane-bound structure. We have re-
cently reported the binding of rFVIII to PS containing LNT
[16]. As the helical organization of the protein decorated
LNT was not suﬃcient to carry out a high resolution structure
analysis, we undertook an extended Cryo-EM study to investi-
gate how the rFVIII organisation depends on the lipid compo-
sition of the LNT.
The aim of the present work is to characterise the rFVIII
binding to LNT at diﬀerent lipid ratio by deﬁning its organisa-
tion by Cryo-EM. Alterations in the arrangement of the pro-
tein molecules, as well as interactions between protein
molecules attached to adjacent LNT were found upon chang-
ing the lipid composition. The conformation of the bound
rFVIII was found to be quite ﬂexible and stabilised by close
protein-protein contact between juxtaposed, rather than side-
by-side molecules. The present study is a step further in under-
standing the function and structure of membrane-bound
rFVIII.blished by Elsevier B.V. All rights reserved.
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2.1. Materials
GalCer:D-galactosyl-b1-10-N-nervonyl-D-erythro-sphingosine (C24:1
b-D-galactosyl ceramide), DOPS: 1,2-dioleoyl-sn-glycero-3-[phospho-
L-serine] and DOPC: 1,2-dioleoyl-sn-glycero-3-phosphocholine were
purchased from Avanti Polar Lipids Inc. (Alabaster, AL). rFVIII-SQ
is gift from the Genetics Institute of Europe B.V.
2.2. LNT formation and rFVIII binding
The lipids solutions in CHCl3 were mixed at diﬀerent ratio and the
solvent evaporated under argon. The dry lipid residue was further
resuspended in 20 mM Tris–HCl buﬀer (pH 7.2) containing 200 mM
imidazole; at a ﬁnal lipid concentration of 0.5 mg/ml. 1000 IU lyophi-
lised rFVIII-SQ was reconstituted in 0.5 ml saline solution. The pro-
tein was added to the LNT solutions and incubated for 30 min at
room temperature.
2.3. Electron microscopy
2.3.1. Negatively stained EM. Carbon coated EM grids were hydro-
philised in an Emitech K100X glow discharger. Five microliter of
the sample was pipetted onto the grid and negatively stained (NS) with
1% solution of uranyl acetate (UA). The NS grids were observed in a
JEOL1200EX, operated at 80 kV and equipped with a Dual vision
(GATAN Inc., UK) camera.
2.3.2. Cryo-EM. Five microliter of the sample was pipetted to a
glow discharged holey carbon grid (Agar Ltd., UK). The sample was
blotted to leave a thin ﬁlm of solution and ﬂash-frozen in liquid ethane
cooled down by liquid nitrogen. The grids were stored, transferred,
and observed in the electron microscope at liquid nitrogen tempera-
tures. Digital micrographs were collected with a JEM2010FEG micro-
scope, at 200 kV, with a 4096 · 4096 pixels CCD camera (Ultrascan
4000, GATAN Inc., 15 lm/pixel resolution) at low electron dose
(<16 e/A2s). All data were acquired at 56000· total magniﬁcation
at ﬁnal resolution of 2.7 A˚/pixel.Table 1
Overview of the LNT quality at diﬀerent lipid compositions
GC (%) PS (%) PC (%) Tubes? Comments
10 30 60 No Vesicles
10 70 20 Few Mostly vesicles
20 30 50 Yes Tubes, large vesicles
20 60 20 Yes Good tubes, vesicles
20 70 10 Yes Good tubes, vesicles
30 70 0 Yes Good tubes, vesicles
40 30 30 Yes Good tubes, vesicles
50 30 0 Yes Good tubes, vesicles
50 30 20 Yes Tubes, MLVs
70 30 0 Yes Very good tubes
90 10 0 Few Short tubes
Fig. 1. Control LNT solutions: (A) at 70:30 (GC:PS), (B) at 30:70 (GC:PS)
carbon edge of the hole in which the sample was frozen in a thin layer of vi2.4. Image analysis
The acquired digital micrographs were further analysed with the
Digital Micrographsoftware (DM, GATAN Inc.) [17].3. Results
3.1. NS-electron microscopy
A full range of lipid compositions were screened by NS-EM
for the presence of LNT, their aggregation state, polydispersity
and length, as well as their suitability for binding rFVIII
(Table 1).
It was observed that below 10% GC mostly vesicles were
present. Once the GC composition was increased to 20%,
LNT were repetitively observed with a high proportion of ves-
icles. The presence of larger vesicles was particularly pro-
nounced in samples with high PS rather than high PC
concentrations. As the GC proportion reached 40% less and
smaller vesicles were observed, except at 50:50 (GC:PS) where
only vesicles were found. When the ratio was altered to
50:30:20 (GC:PS:PC) the LNT were the dominant structure
mixed with large multilamellar vesicles. At 90% GC only few
and short LNT were formed.
3.2. Cryo-electron microscopy
As good LNT were present in all conditions above 20% GC,
we selected only three for the Cryo-EM and protein binding
experiments: 30:70 and 70:30 (GC:PS), and 50:30:20
(GC:PS:PC). The Cryo-EM micrographs for all three condi-
tions revealed single LNT with an outer diameter of
30 ± 1 nm, lengths of 300–1000 nm (typical lengths of 500–
600 nm) and well resolved lipid bilayer with a constant thick-
ness of 6.0 ± 1 nm (Fig. 1). Groups of single and clustered
LNT were observed along with individual LNT (Fig. 1). Small
vesicles were present in both 70:30 (GC:PS) and 50:30:20
(GC:PS:PC) conditions, constituting at most 10% of the pop-
ulation (Fig. 1A and C). At 30:70 (GC:PS) the vesicles popu-
lation was more dense and often large and multilamellar
(LMVs) vesicles, in near equal proportion with the LNT, were
observed (Fig. 1B).
Cryo-EM of the LNT with bound rFVIII showed that in all
three selected lipid conditions the protein covered well the lipid
surface. At closer inspection, diﬀerent arrangements of the
rFVIII were observed, suggesting a change in the membrane-
bound conformation of the protein in each condition
(Fig. 2). At 70:30 (GC:PS), we observed clustered LNT withwith LMVs indicated by arrows and (C) at 50:30:20 (GC:PS:PC). The
triﬁed buﬀer is indicated by stars. Scale bar: 100 nm.
Fig. 2. rFVIII bound to the control LNT. (A) rFVIII bound to 70:30 (GC:PS) LNT. Arrows indicate ‘‘zipper’’-type structures and arrow heads
indicate individual LNT covered with rFVIII. (B) rFVIII attached to 30:70 (GC:PS) LNT. Arrows indicate well ordered protein molecules onto the
LNT. Arrow heads indicate vesicle at the end of a nanotube, covered with protein. (C) rFVIII bound to 50:30:20 (GC:PS:PC) LNT. Arrows indicates
a pack of parallel LNT with attached protein molecules.
Fig. 3. (A) 1024 · 1024 boxed area (0.27 nm/pixel) from Fig. 2A and corresponding Fourier transform (Inset). (B) Fourier ﬁltered image of the
masked area (5 pixels in diameter) around the main diﬀraction peaks on the Fourier transform (inset). The protein/lipid densities are in white. (C)
Histogram of the ‘‘zipper’’ structure between the two LNT, along the green dashed line on (B). The two red dashed lines indicated the ‘‘zipper’’
thickness of 18 nm.
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ing LNT, as well as individual tubes with bound rFVIII and
without a pronounced helical organisation (Fig. 2A). The
LNT at 30:70 (GC:PS) were more densely covered with protein
(Fig. 2B). No ‘‘zipper’’ structures were observed and MLVs
were not present, as for the control LNT at the same lipid com-
position. At 50:30:20 (GC:PS:PC), the individual protein mol-
ecules were well deﬁned onto the LNT (Fig. 2C) with a similar
arrangement as for the LNT at 70:30 (GC:PC) (Fig. 2A). All
conditions showed a clear tendency to form parallel clusters
of LNT, however deﬁned ‘‘zipper’’-type structures were found
only for the LNT with bound rFVIII, formed at 70:30
(GC:PS).
3.3. Image analysis
We have further analysed some of the ‘‘zipper’’ structures to
better understand their signiﬁcance (Fig. 3). The Fourier trans-
form of a ‘‘zipper’’ structure from Fig. 1A, showed a typical
helical diﬀraction pattern (Fig. 3A), asserting a helical organi-
sation. A Fourier ﬁlter was further applied, by masking out the
main visible peaks from the Fourier transform in Fig. 3A (in-
set). Performing an inverse Fourier transform on the masked
area (Fig. 3B, inset) gives a Fourier ﬁltered image containing
only the information from the original image, which contrib-
utes to the helical organisations of the ‘‘zipper’’ structure.Thus, it is unambiguously proved that this organisation results
from the protein molecules organised between two adjacent
LNT, rather than on the same LNT (Fig. 3B). Masking the dif-
fraction peaks in the equatorial middle lane reconstruct also
the signal corresponding to the LNT bilayer. The width of a
‘‘zipper’’ is 18 ± 1 nm, compared to the LNT diameter within
a cluster, which is 20 ± 1 nm (minimum to minimum, i.e. the
centre of the bilayer) (Fig. 3C). The outer diameter of a single
LNT within a cluster is consistently smaller compared to the
outer diameter of a single LNT: 25 ± 1 nm (Fig. 1).4. Discussion
Previously, we have proved that rFVIII binds to LNT at
70:30 (GC:PS) [16] fully covering the outer surface. In this
study, we have investigate further how the lipid composition
and more speciﬁcally the PS concentration will aﬀect the orga-
nisation of the membrane-bound rFVIII. From the lipid layer
crystallisation experiments, we know that changes in the PS
concentration aﬀect the 2D organisation of the bound FVIII
[18,19]. Higher PS content gives better ordered 2D arrays
and tubes. In the case of GC LNT, low concentration of GC
shifts the equilibrium from tubes to vesicles with suﬃcient
quantities of good LNT obtained above 20% GC. Varying
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the quality of the LNT but rather the tubes to vesicles ratio
and the vesicles size.
From the three selected conditions, the 70:30 (GC:PS) mim-
ics the native PS content of the platelet membrane. The 30:70
(GC:PS) was selected as a high PS condition and the 50:30:20
(GC:PS:PC) to test how changes in the overall surface charge/
ﬂuidity of the bilayer aﬀects the rFVIII organisation, while
keeping the PS content as in the native platelet membrane.
All three conditions showed tendency for parallel arrange-
ments of the LNT, a common behaviour observed with axial
colloid particles in solution, which depends of the surface
charge and concentration [20]. The rFVIII organisation onto
the LNT with the same PS content (30%) were very similar
(Fig. 2A and C). Reducing the GC from 70% to 50% by
replacement with PC abolished the formation of the ‘‘zip-
per’’-type structures between adjacent LNT, strongly suggest-
ing that despite the same PS content, the membrane-bound
conformation of rFVIII has been altered and the protein–pro-
tein interactions between adjacent and juxtaposed rFVIII mol-
ecules, aﬀected. Increasing the PS to 70% led to a denser
packing of the protein molecules without reaching a better
helical organisation, thus conﬁrming that a degree of ﬂuidity
is required for the speciﬁc protein–protein interactions to ob-
tain well ordered LNT, rather than a simple increase in protein
concentration at the LNT surface [18,19]. The lack of MLVs
upon addition of the protein also conﬁrms that the rFVIII
has a stabilising eﬀect on the LNT, shifting the equilibrium
from vesicles to tubes. This indicates a change in the surface
tension of the membrane due to a possible deeper insertion
of the protein, aﬀecting its curvature [19].
The newly found ‘‘zipper’’ structures width corresponds to
the height of two protein molecules interacting head-to-head,
as previously calculated from EM studies of membrane-bound
FVIII [18]. These interactions imply that the protein-LNT are
indeed helically organised and stabilised by protein–protein
interactions between adjacent LNT. The ‘‘zipper’’ structures
reﬂect the arrangement of the already formed helical LNT
and are unlikely to be the result of new protein–protein interac-
tions.5. Conclusions
Alterations in the lipid composition of the GC LNT have a
deﬁned eﬀect on the membrane-bound organisation of the spe-
ciﬁcally attached rFVIII molecules. The changes in the diame-
ter of the LNT, when single and in parallel clusters, as well as
the formation of ‘‘zipper’’ structures between adjacent LNT,
showed that the nanotubes membrane is very soft and the
membrane-bounding of rFVIII quite ﬂexible. Stabilising the
protein conformation by varying further the lipid composition
or obtaining more ‘‘zipper’’-like structures will help to improve
the helical organisation required for a high resolution structure
determination of membrane-bound rFVIII by Cryo-EM.
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